| pubmed-article:12161162 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12161162 | lifeskim:mentions | umls-concept:C0078056 | lld:lifeskim |
| pubmed-article:12161162 | lifeskim:mentions | umls-concept:C0209606 | lld:lifeskim |
| pubmed-article:12161162 | lifeskim:mentions | umls-concept:C1421435 | lld:lifeskim |
| pubmed-article:12161162 | lifeskim:mentions | umls-concept:C0243076 | lld:lifeskim |
| pubmed-article:12161162 | lifeskim:mentions | umls-concept:C0243072 | lld:lifeskim |
| pubmed-article:12161162 | pubmed:issue | 17 | lld:pubmed |
| pubmed-article:12161162 | pubmed:dateCreated | 2002-8-5 | lld:pubmed |
| pubmed-article:12161162 | pubmed:abstractText | A series of N-benzoyl-4-[(2,6-dichlorobenzoyl)amino]-L-phenylalanine derivatives was prepared in order to optimize the substitution on the N-benzoyl moiety for VCAM/VLA-4 antagonist activity. Disubstitution in the 2- and 6-positions is favored and a range of small alkyl and halogen are tolerated. A model of the bioactive conformation of these compounds is proposed. | lld:pubmed |
| pubmed-article:12161162 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12161162 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12161162 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12161162 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12161162 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12161162 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12161162 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12161162 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12161162 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12161162 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:12161162 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:12161162 | pubmed:author | pubmed-author:ChenLiL | lld:pubmed |
| pubmed-article:12161162 | pubmed:author | pubmed-author:RowanKarenK | lld:pubmed |
| pubmed-article:12161162 | pubmed:author | pubmed-author:SchwingeVirgi... | lld:pubmed |
| pubmed-article:12161162 | pubmed:author | pubmed-author:CampbellRober... | lld:pubmed |
| pubmed-article:12161162 | pubmed:author | pubmed-author:HuangTai-NanT... | lld:pubmed |
| pubmed-article:12161162 | pubmed:author | pubmed-author:TilleyJeffers... | lld:pubmed |
| pubmed-article:12161162 | pubmed:author | pubmed-author:SidduriAchyut... | lld:pubmed |
| pubmed-article:12161162 | pubmed:author | pubmed-author:LouJian... | lld:pubmed |
| pubmed-article:12161162 | pubmed:author | pubmed-author:KaplanGerryG | lld:pubmed |
| pubmed-article:12161162 | pubmed:author | pubmed-author:GuthrieRobert... | lld:pubmed |
| pubmed-article:12161162 | pubmed:author | pubmed-author:RenzettiLouis... | lld:pubmed |
| pubmed-article:12161162 | pubmed:author | pubmed-author:MennonaFrankF | lld:pubmed |
| pubmed-article:12161162 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12161162 | pubmed:day | 2 | lld:pubmed |
| pubmed-article:12161162 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:12161162 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12161162 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12161162 | pubmed:pagination | 2479-82 | lld:pubmed |
| pubmed-article:12161162 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:12161162 | pubmed:meshHeading | pubmed-meshheading:12161162... | lld:pubmed |
| pubmed-article:12161162 | pubmed:meshHeading | pubmed-meshheading:12161162... | lld:pubmed |
| pubmed-article:12161162 | pubmed:meshHeading | pubmed-meshheading:12161162... | lld:pubmed |
| pubmed-article:12161162 | pubmed:meshHeading | pubmed-meshheading:12161162... | lld:pubmed |
| pubmed-article:12161162 | pubmed:meshHeading | pubmed-meshheading:12161162... | lld:pubmed |
| pubmed-article:12161162 | pubmed:meshHeading | pubmed-meshheading:12161162... | lld:pubmed |
| pubmed-article:12161162 | pubmed:meshHeading | pubmed-meshheading:12161162... | lld:pubmed |
| pubmed-article:12161162 | pubmed:meshHeading | pubmed-meshheading:12161162... | lld:pubmed |
| pubmed-article:12161162 | pubmed:meshHeading | pubmed-meshheading:12161162... | lld:pubmed |
| pubmed-article:12161162 | pubmed:meshHeading | pubmed-meshheading:12161162... | lld:pubmed |
| pubmed-article:12161162 | pubmed:meshHeading | pubmed-meshheading:12161162... | lld:pubmed |
| pubmed-article:12161162 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12161162 | pubmed:articleTitle | N-Aroyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists. | lld:pubmed |
| pubmed-article:12161162 | pubmed:affiliation | Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110, USA. achyutharao.sidduri@roche.com | lld:pubmed |
| pubmed-article:12161162 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:12161162 | lld:chembl |
